| Literature DB >> 16211090 |
Sarah E Allan1, Laura Passerini, Rosa Bacchetta, Natasha Crellin, Minyue Dai, Paul C Orban, Steven F Ziegler, Maria Grazia Roncarolo, Megan K Levings.
Abstract
Little is known about the molecules that control the development and function of CD4+ CD25+ Tregs. Recently, it was shown that the transcription factor FOXP3 is necessary and sufficient for the generation of CD4+ CD25+ Tregs in mice. We investigated the capacity of FOXP3 to drive the generation of suppressive CD4+ CD25+ Tregs in humans. Surprisingly, although ectopic expression of FOXP3 in human CD4+ T cells resulted in induction of hyporesponsiveness and suppression of IL-2 production, it did not lead to acquisition of significant suppressor activity in vitro. Similarly, ectopic expression of FOXP3delta2, an isoform found in human CD4+ CD25+ Tregs that lacks exon 2, also failed to induce the development of suppressor T cells. Moreover, when FOXP3 and FOXP3delta2 were simultaneously overexpressed, although the expression of several Treg-associated cell surface markers was significantly increased, only a modest suppressive activity was induced. These data indicate that in humans, overexpression of FOXP3 alone or together with FOXP3delta2 is not an effective method to generate potent suppressor T cells in vitro and suggest that factors in addition to FOXP3 are required during the process of activation and/or differentiation for the development of bona fide Tregs.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16211090 PMCID: PMC1242190 DOI: 10.1172/JCI24685
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808